Increased susceptibility to sporadic Parkinson's disease by a certain combined ?-synuclein/apolipoprotein E genotypeRejko Kr�ger, Olaf Rieß, Daniela Berg et al.|Annals of Neurology|1999Cited by 279
AFQ056 treatment of levodopa‐induced dyskinesias: Results of 2 randomized controlled trialsDaniela Berg, Baltazar Gomez‐Mancilla, Karla Eggert et al.|Movement Disorders|2011Cited by 173
α-Synuclein in Parkinson’s disease: causal or bystander?Peter Riederer, Camelia‐Maria Monoranu, Daniela Berg et al.|Journal of Neural Transmission|2019Cited by 114
Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE studyElke Kalbe, Richard Dodel, Daniela Berg et al.|Journal of Neurology Neurosurgery & Psychiatry|2016Cited by 102
Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognitionJennifer Wojtala, Kathrin Reetz, Daniela Berg et al.|Journal of Neurology Neurosurgery & Psychiatry|2018Cited by 87